Clinical trials: Pregnancy Rate
Infertility
Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF
The primary objective of this study is to confirm the efficacy of a single oral 900 mg dose of nolasiban versus placebo to increase the ongoing clinical pregnancy rate at 10 weeks post-embryo transfer (ET) day.
- Trial name
- IMPLANT4 (NCT03758885)
- Testing
- Nolasiban
- Where
- 50 sites in Belgium, Canada and 8 more
- Volunteers
- 820 people
- Sponsor
- ObsEva SA